CLINICAL

Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer
Keun Hur, Yuji Toiyama, Yoshinaga Okugawa, Shozo Ide, Hiroki Imaoka, C Richard Boland, Ajay Goel

Gut Apr 2017, 66 (4) 654-665; DOI: 10.1136/gutjnl-2014-308737
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold, Mónica S Sierra, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray

Gut Apr 2017, 66 (4) 683-691; DOI: 10.1136/gutjnl-2015-310912
Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer
F Amicarella, M G Muraro, C Hirt, E Cremonesi, E Padovan, V Mele, V Governa, J Han, X Huber, R A Droeser, M Zuber, M Adamina, M Bolli, R Rosso, A Lugli, I Zlobec, L Terracciano, L Tornillo, P Zajac, S Eppenberger-Castori, F Trapani, D Oertli, G Iezzi

Gut Apr 2017, 66 (4) 692-704; DOI: 10.1136/gutjnl-2015-310016
MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6–p47^phox–oxidative stress pathway in neutrophils
Man Li, Yong He, Zhou Zhou, Teresa Ramirez, Yueqiu Gao, Yanhang Gao, Ruth A Ross, Haixia Cao, Yan Cai, Mingjiang Xu, Dechun Feng, Ping Zhang, Suthat Liangpunsakul, Bin Gao

Gut Apr 2017, 66 (4) 705-715; DOI: 10.1136/gutjnl-2016-311861
PGAM5-mediated programmed necrosis of hepatocytes drives acute liver injury
Gui-Wei He, Claudia Günther, Andreas E Kremer, Veronika Thonn, Kerstin Amann, Christopher Poremba, Markus F Neurath, Stefan Wirtz, Christoph Becker

Gut Apr 2017, 66 (4) 716-723; DOI: 10.1136/gutjnl-2015-311247
Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis
Carl-Philipp Hackstein, Lisa Mareike Assmus, Meike Welz, Sabine Klein, Timo Schwandt, Joachim Schultze, Irmgard Förster, Fabian Gondorf, Marc Beyer, Daniela Kroy, Christian Kurts, Jonel Trebicka, Wolfgang Kastenmüller, Percy A Knolle, Zeinab Abdullah

Gut Mar 2017, 66 (3) 507-518; DOI: 10.1136/gutjnl-2015-311224
Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidase
Nikhil Vergis, Wafa Khamri, Kylie Beale, Fouzia Sadiq, Mina O Aletrari, Celia Moore, Stephen R Atkinson, Christine Bernsmeier, Lucia A Possamai, Gemma Petts, Jennifer M Ryan, Robin D Abeles, Sarah James, Matthew Foxton, Brian Hogan, Graham R Foster, Alastair J O'Brien, Yun Ma, Debbie L Shawcross, Julia A Wendon, Charalambos G Antoniades, Mark R Thursz

Gut Mar 2017, 66 (3) 519-529; DOI: 10.1136/gutjnl-2015-310378
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
Victoria Tovar, Helena Cornella, Agrin Moeini, Samuel Vidal, Yujin Hoshida, Daniela Sia, Judit Peix, Laia Cabellos, Clara Alsinet, Sara Torrecilla, Iris Martinez-Quetglas, Juan José Lozano, Christèle Desbois-Mouthon, Manel Solé, Josep Domingo-Domenech, Augusto Villanueva, Josep M Llovet

Gut Mar 2017, 66 (3) 530-540; DOI: 10.1136/gutjnl-2015-309501
Ethics and hepatitis B cure research
Jeremy Sugarman, Peter Revill, Fabien Zoulim, Yazdan Yazdanpanah, Harry L A Janssen, Seng Gee Lim, Sharon R Lewin

Gut Mar 2017, 66 (3) 389-392; DOI: 10.1136/gutjnl-2016-313009
The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis
Oliver M Fisher, Sarah J Lord, Dan Falkenback, Nicholas J Clemons, Guy D Eslick, Reginald V Lord

Gut Mar 2017, 66 (3) 399-410; DOI: 10.1136/gutjnl-2015-310888

Main menu

CLINICAL

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

CLINICAL

Pages